✦ LIBER ✦

Survival Advantage in CLL with Frontline FCR Therapy

✍ Scribed by Susan O’Brien

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second Cancers (SC) Affect the Clinical

✍ Benjamini, Ohad; Trinh, Long; Jain, Preetesh; Wang, Xuemei; Chae, Young-Kwang; L 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 210 KB

What is the Best Frontline Therapy for P

✍ Xavier C. Badoux; Michael J. Keating; William G. Wierda 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 257 KB

Interferon-α therapy maintains survival

📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 185 KB

Long survival in B-CLL correlates with s

✍ T. J. Hamblin; D. G. Oscier; J. R. Stevens; J. L. Smith 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB

P-202 MDS development risk in CLL patien

✍ Jonasova, A.; Obrtlikova, P.; Siskova, M.; Cmunt, E.; Berkova, A.; Karban, J.; S 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Targeted therapy with erlotinib prolongs

✍ James R. Rigas; Konstantin H. Dragnev 📂 Article 📅 2005 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 171 KB